Tumor-released microvesicles as vehicles of immunosuppression - PubMed (original) (raw)
Review
Tumor-released microvesicles as vehicles of immunosuppression
Roberta Valenti et al. Cancer Res. 2007.
Abstract
Tumor-released microvesicles, or exosomes, which are abundant in the body fluids of patients with cancer, are likely to be involved in tumor progression. We recently showed that microvesicles released by human melanoma and colorectal carcinoma cells can promote the differentiation of monocytes to myeloid-derived suppressor cells which support tumoral growth and immune escape. These findings underscore an important role for these extracellular organelles in remodeling tumor-stromal interactions to promote malignancy.
Similar articles
- Tumour-released exosomes and their implications in cancer immunity.
Iero M, Valenti R, Huber V, Filipazzi P, Parmiani G, Fais S, Rivoltini L. Iero M, et al. Cell Death Differ. 2008 Jan;15(1):80-8. doi: 10.1038/sj.cdd.4402237. Epub 2007 Oct 12. Cell Death Differ. 2008. PMID: 17932500 Review. - Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.
Marigo I, Dolcetti L, Serafini P, Zanovello P, Bronte V. Marigo I, et al. Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Immunol Rev. 2008. PMID: 18364001 Review. - Myeloid-derived suppressor cell role in tumor-related inflammation.
Dolcetti L, Marigo I, Mantelli B, Peranzoni E, Zanovello P, Bronte V. Dolcetti L, et al. Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433992 Review. - Tumor-derived exosomes as mediators of disease and potential diagnostic biomarkers.
Roberson CD, Atay S, Gercel-Taylor C, Taylor DD. Roberson CD, et al. Cancer Biomark. 2010-2011;8(4-5):281-91. doi: 10.3233/CBM-2011-0211. Cancer Biomark. 2010. PMID: 22045359 - Recent advances on the role of tumor exosomes in immunosuppression and disease progression.
Filipazzi P, Bürdek M, Villa A, Rivoltini L, Huber V. Filipazzi P, et al. Semin Cancer Biol. 2012 Aug;22(4):342-9. doi: 10.1016/j.semcancer.2012.02.005. Epub 2012 Feb 19. Semin Cancer Biol. 2012. PMID: 22369922 Review.
Cited by
- Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer.
Khan S, Jutzy JM, Valenzuela MM, Turay D, Aspe JR, Ashok A, Mirshahidi S, Mercola D, Lilly MB, Wall NR. Khan S, et al. PLoS One. 2012;7(10):e46737. doi: 10.1371/journal.pone.0046737. Epub 2012 Oct 16. PLoS One. 2012. PMID: 23091600 Free PMC article. - Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis.
Kawamoto T, Ohga N, Akiyama K, Hirata N, Kitahara S, Maishi N, Osawa T, Yamamoto K, Kondoh M, Shindoh M, Hida Y, Hida K. Kawamoto T, et al. PLoS One. 2012;7(3):e34045. doi: 10.1371/journal.pone.0034045. Epub 2012 Mar 30. PLoS One. 2012. PMID: 22479517 Free PMC article. - Melanoma exosomes enable tumor tolerance in lymph nodes.
Hood JL. Hood JL. Med Hypotheses. 2016 May;90:11-3. doi: 10.1016/j.mehy.2016.02.018. Epub 2016 Feb 27. Med Hypotheses. 2016. PMID: 27063077 Free PMC article. - Small extracellular vesicles in cancer.
Abhange K, Makler A, Wen Y, Ramnauth N, Mao W, Asghar W, Wan Y. Abhange K, et al. Bioact Mater. 2021 Apr 7;6(11):3705-3743. doi: 10.1016/j.bioactmat.2021.03.015. eCollection 2021 Nov. Bioact Mater. 2021. PMID: 33898874 Free PMC article. Review. - Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes.
Wieckowski EU, Visus C, Szajnik M, Szczepanski MJ, Storkus WJ, Whiteside TL. Wieckowski EU, et al. J Immunol. 2009 Sep 15;183(6):3720-30. doi: 10.4049/jimmunol.0900970. Epub 2009 Aug 19. J Immunol. 2009. PMID: 19692638 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources